I guess, the professor didn’t read the patent application. For instance: [0019] In other aspects, the invention relates to the use of the isolated hEbola virus for diagnostic and therapeutic methods based on EbBun, EboIC, or a combination thereof. In one embodiment, the invention provides a method of detecting in a biological sample an antibody immunospecific for the genus of West Afrin Ebola Species constituting hEbola EbBun and EboIC
He also must of missed the application date in 2008 or final issuing date in 2010. There is money in finding treatments and they are protecting their research.
But he did not miss the part where the patent claims to cover all ebola virus variants with as little as 70% similarity to the virus they patented. (covers all of them)